Luxturnahcp.com
Top lux sites |
Top turn sites |
Top hcp sites |
- Title
- LUXTURNA™ (voretigene neparvovec-rzyl) for HCPs
- Meta Description
- Learn about LUXTURNA™ (voretigene neparvovec-rzyl), the first FDA-approved gene therapy for a genetic disease
- Meta Keywords
- LUXTURNA, gene therapy for retinal dystrophy, rod cone dystrophy gene therapy, RPE65, RPE65 gene, RPE65 gene therapy, voretigene, neparvovec-rzyl, retinal dystrophy, retinal dystrophy treatment, inherited retinal disease, ird, inherited retinal disease treatment
- Technologies in use
- Google Analytics, jQuery
Server | Apache |
Last-Modified | Fri, 22 Dec 2017 17: |
ETag | "5f94-560f153431a47- |
Accept-Ranges | bytes |
Vary | Accept-Encoding |
Content-Encoding | gzip |
Access-Control-Allow-Headers | ORIGIN, X-REQUESTED- |
Access-Control-Allow-Methods | POST, GET, OPTIONS, |
Access-Control-Allow-Origin | * |
Access-Control-Allow-Credentials | true |
Keep-Alive | timeout=5, max=100 |
Connection | Keep-Alive |
Content-Type | text/html |